Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

Share Price is delayed by 15 minutes
Get Live Data
590.00    11.00 (1.90%)
Bid:
589.00
Ask:
591.00
Spread: 2.00 (0.34%)
Market Cap: £857.80m
SAGA Live PriceLast checked at - London Stock Exchange

Intraday Saga Share Chart

Trading Update

6 Dec 2017 07:00

RNS Number : 4903Y
SAGA PLC
06 December 2017
Β 

6 December 2017

Β 

Saga plc

Trading update

Β 

Saga plc ("Saga" or "the Group"), the UK's specialist in products and services for life after 50, announces a trading update for the period from 1 August 2017 to 5 December 2017 ("the period").

Trading update

The Group's growth in Underlying PBT1 is expected to be between 1% and 2% for the year ended 31 January 2018. This has been impacted by more challenging trading in insurance broking during the period and the Monarch Airlines administration, which has affected our Tour Operations business.

For the full year, the written profit of our Retail Broking business is expected to be ahead year on year, with a strong performance in motor partially offset by a challenging trading environment in home and travel insurance. Earned profit for Retail Broking is expected to be marginally lower than the prior year due to a lower written to earned benefit.

Our in-house underwriter has continued to have an excellent experience in small and large personal injury claims and we now expect reserve releases to be at a similar level to the previous year.

Our Travel segment continues to trade well and is expected to be strongly ahead of the prior year. However, the Tour Operations business has been impacted by the collapse of Monarch Airlines with an approximate one-off cost of Β£2 million.

During the period, we have completed a review of our operating structure which will realise approximately Β£10 million of annualised savings next year. We expect to incur a one-off cost of circa Β£4 million relating to these changes, excluded from Underlying PBT.

_______

1Β Profit before tax excluding fair value gains and losses on derivatives, debt write-off and restructuring costs.

Β 

Investing for growth

Since IPO, we have been investing in our capabilities. Our new claims platform is now live and our broking platform is in the final stages of testing. The renewal of our shipping fleet is underway. We have launched our motor panel and our membership program, Possibilities. We have improved our ability to attract, retain and grow our High Affinity Customers ("HACs"). With greater customer insight and a stronger business platform, now is the right time for us to make targeted marketing investments to grow the business.

As a result we intend to increase our annual customer acquisition spend by Β£10 million starting next year.Β 

Guidance

We expect an increase in the profitability of our Broking and Travel businesses next year, including the approximately Β£10 million of annualised savings from the actions we have taken in the current year. Offsetting this will be a lower level of written to earned benefit and a decline in reserve releases, as discussed below. These headwinds and our decision to invest an additional Β£10 million into customer acquisition is expected to result in Underlying PBT for next year being approximately 5% lower than the current year.

We expect the current year dividend to be in line with our expectations, and we remain fully committed to our stated dividend policy.

Retail Broker - written to earned adjustment

Our transition towards a capital light broker model has involved the introduction of the motor panel and the transfer of broked add-ons to third parties from our in-house provider. These changes and the introduction of an arrangement fee in 2015 have resulted in a benefit from recognising these revenues on a written basis. The benefit in the year ended 31 January 2017 was Β£19.9 million, and this is expected to decline by Β£10 million in the current year, and then not recur.

Underwriting - reserve releases

Whilst the in-year profitability of our underwriter continues to perform as expected, the level of reserve releases related to historical claim years is expected to decline by between Β£10 million and Β£15 million next year.

Business growth

With the additional investment in customer acquisition, we expect numbers of Retail Broking policies and holiday passengers to return to growth.

We continue to be on track to achieve our goal of increasing the profit before tax of our travel segment by 4-5 times by the year ended 31 January 2022.Β 

Notice of results

Saga will announce its preliminary results for the year ending 31 January 2018 on 12 April 2018.

Lance Batchelor, CEO, said:

"Against a backdrop of some challenging trading conditions in our final quarter, we continue to develop the business for the long term. With greater customer insight and a stronger business platform, now is the right time for Saga to invest in growing the customer base and the business.

We are confident that the actions taken will ultimately see a better quality of earnings and profit growth across the business, supporting our progressive dividend policy for the benefit of our shareholders."

END

Β 

There will be a call at 8.30am today for analysts and investors. To register for the call please contact MHP Communications on +44 (0)20 3128 8219 or 8742, or by email on saga@mhpc.com

Saga plc

Mark Watkins, Director of Investor Relations Tel: 07738 777 479

Email: mark.watkins@saga.co.uk

Β 

MHP

Tim Rowntree/Simon Hockridge/Reg Hoare Tel: 020 3128 8742

Email: saga@mhpc.com

Β 

Β 

Notes to editors

Saga is a specialist in the provision of products and services for life after 50. The Saga brand is one of the most recognised and trusted brands in the UK and is known for its high level of customer service and its high quality, award winning products and services including cruises and holidays, insurance, personal finance and publishing. saga.co.uk

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTOKPDPDBDBPBK
Date   Source Headline
26th May 20269:00 amRNSNotice of AGM/ Annual Report and Accounts
12th May 20264:23 pmRNSTotal Voting Rights
8th May 202611:45 amRNSIssue of Equity
23rd Apr 20264:42 pmRNSDirector/PDMR Shareholding
23rd Apr 20264:40 pmRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSPreliminary results for the year ended 31 Jan 2026
23rd Mar 20261:59 pmRNSCommittee Changes
3rd Mar 20267:00 amRNSAppointment of Joint Corporate Brokers
27th Feb 20264:00 pmRNSDirectorate change
29th Jan 20267:00 amRNSTrading Update
16th Dec 20257:00 amRNSSaga and Ageas Insurance partnership goes live
30th Sep 20252:40 pmRNSHolding(s) in Company
29th Sep 202510:15 amRNSDirector/PDMR Shareholding
24th Sep 20257:00 amRNS2025-26 interim results statement
15th Jul 20259:00 amRNSTotal Voting Rights
14th Jul 20257:00 amRNSSaga Money launches partnership with NatWest
9th Jul 202512:00 pmRNSCommittee changes
9th Jul 202511:49 amRNSIssue of Equity
1st Jul 20253:57 pmRNSHolding(s) in Company
1st Jul 20252:09 pmRNSAcromas Insurance Company Limited Completion
26th Jun 20251:49 pmRNSDirector/PDMR Shareholding
24th Jun 20251:13 pmRNSResult of AGM
24th Jun 20259:02 amRNSDirector Declaration
24th Jun 20257:00 amRNSAGM Trading Update
29th May 20252:38 pmRNSDirector/PDMR Shareholding
20th May 20259:00 amRNSNotice of AGM
11th Apr 202511:00 amRNSHolding(s) in Company
10th Apr 20257:30 amRNSDirector/PDMR Shareholding
9th Apr 20253:54 pmRNSDirector/PDMR Shareholding
9th Apr 20257:01 amRNSDirectorate Change
9th Apr 20257:00 amRNSFinal Results
13th Mar 20258:00 amRNSDirector Declaration
28th Feb 20257:00 amRNSRepayment of corporate debt and new draw down
12th Feb 20258:00 amRNSDirector Declaration
30th Jan 20257:01 amRNSTrading Update
30th Jan 20257:00 amRNSSaga successfully refinances corporate debt
16th Dec 20247:00 amRNSSaga and Ageas agree new Insurance partnership
10th Dec 20243:57 pmRNSDirector Declaration
24th Oct 20247:35 amRNSDirector Declaration
24th Oct 20247:35 amRNSCorrection - Director Declaration
11th Oct 20247:00 amRNSInterim results for the six months ended 31 July
11th Oct 20247:00 amRNSSaga and Ageas in exclusive negotiations
2nd Oct 20247:00 amRNSResponse to Media Coverage
1st Oct 20244:23 pmRNSDelay to publication of H1 2024 results
1st Oct 20248:59 amRNSDirector Declaration
9th Jul 20241:00 pmRNSDirector/PDMR Shareholding
25th Jun 20243:00 pmRNSCorrection - Result of AGM
25th Jun 20242:19 pmRNSResult of AGM
25th Jun 20247:00 amRNSAGM Trading Update
12th Jun 20244:52 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.